photodynamic therapySmall cell lung cancer (SCLC)SCLCPROTAC
…ed locally at the tumor site to penetrate the tumor and enhance photodynamic therapy (PDT), thus precisely induced bromodomain and extraterminal pro…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,561–1,620 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
DTG-for-All1DoxyPEP1E7 TCR-T cell therapy1EBCR1EBP1EDA1EN1EQ-5D-5L1ERP1ESD-RBC1ETA1ETI1EV/P1Early palliative care1Elective MMAE1Endoscopic full-thickness resection1Endoscopic hand suturing1Endovascular electrocoagulation1Energy-restricted diets1Exclusion diets1External neurostimulation1FD1FES1FOLFOX chemotherapy1Folic acid supplementation1Fontan procedure1GGAS1GLP-1 therapy1HAT1HCV cure1HE-DMT1HF therapy1HIET1HPV vaccination1HR-CTA1HSCT1Head and neck radiation1Hip and knee replacements1His bundle pacing1Home-based therapy1IC1ICI monotherapy1ICSI1IL-1 blockade1IPACK1ISBPB1Immune checkpoint blockades1Intensive therapies1Intra-arterial infusion1Intracranial stenting1Intravenous thrombolytics1KT1LDC1LET1LVO-Alert1Laparoscopic excision1Laparoscopic pericardioperitoneal window1Laughter1Laxatives1Loop sigmoidostomy1
Articles mentioning treatments
7,227 articles · page 492 of 603CAR-T therapiessolid tumorshematologic malignanciesCAR-T
…Background Several CAR-T therapies have been approved for hematologic malignancies. However despit…
Cellular immunotherapieshematological malignanciesTravirtideProtransduzin-BVectofusin-1
…Background Cellular immunotherapies using genetically reprogrammed immune cells, such as T-lymphocy…
immunotherapiesSolid tumorsovarian cancersbreasthematologic malignancies
…y in the U.S. Despite advances in surgery, targeted agents, and immunotherapies, durable responses remain limited. Both ex vivo and in vivo chi…
Chimeric antigen receptor T (CAR-T) cell therapieshematological cancersolid tumorsgraft-versus-host diseasesolid cancerxenograft mouse models
…Background Chimeric antigen receptor T (CAR-T) cell therapies are a form of adoptive cell therapy that has shown promising cl…
83.5%
anti-cancer interventionsThe Ohio State UniversityPancreatic Ductal Adenocarcinoma (PDAC)Ohio State UniversityAssociation for Assessment and Accreditation of Laboratory Animal Care International
…systemic inflammation, cachexia reduces the efficacy of various anti-cancer interventions and enhances the morbidity of PDAC. Recent research suggests th…
Adoptive cell therapy (ACT)University of Pittsburghcancers
…Background Adoptive cell therapy (ACT), in which T cells are isolated from a patient, expanded to high…
chimeric antigen receptor T (CART) cell therapyMayo Clinic Division of HematologyMayo Clinic Center for Individualized Medicine4-1BBMayo Clinic
…Background Despite the high initial responses to chimeric antigen receptor T (CART) cell therapy, most patients relapse within the first 1-2 years. Patient-deri…
CAR T cell therapysolid tumorsDIPGpediatric brain tumorshematologic malignanciespediatric high-grade gliomasdiffuse intrinsic pontine glioma (DIPG)NLVIL13Rα2-targeting 41BB-based CARNLVPMVATV+2 more
…Background CAR T cell therapy has transformed the treatment landscape for hematologic maligna…
immunotherapyLung cancer
…lecular disparities may impact access to targeted therapies and immunotherapy. Although prior studies report variations in genetic alteration…
chimeric antigen receptor (CAR) T-cell therapyDiffuse Intrinsic Pontine GliomaDIPG
… brain tumor with median survival of less than 12 months. While chimeric antigen receptor (CAR) T-cell therapy shows promise, its efficacy in DIPG is limited by a profoundly …
CAR-T cell therapyNeuroblastomaGD2BBDAP12University of Wisconsin-MadisonGD2BBζ
…astoma cells has provided a target for immunotherapy, including CAR-T cell therapy. Recently published work using anti-GD2 CAR-T cells in relapsed…